Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT05059938

MyFitnessPal Pilot Study

Promoting the Use of Free Smartphone App (MyFitnessPal) for Weight Loss by Primary Care Provider in Overweight Patients: A Randomized Controlled Pilot Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Geisinger Clinic · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Accepted

Summary

This project is studying whether patients who use MyFitnessPal as an aid to weight loss have more success than patients who are only given traditional medical guidance from the patient's physician.

Detailed description

Patients will be given a survey determining the patient's eligibility to be part of the study. Based on the results patients will be consented and then randomized into two arms. The intervention group will download MyFitnessPal onto the patient's smartphone and given guidance on how to use the application in order to help with weight loss. The control group will receive traditional weight loss counseling from the physician. Both groups will have measurement recorded for weight, blood pressure, and waist circumference at the patient's initial visit. All patients will be asked to return to the clinic at no cost to the patient to have measurements recorded for the patient's weight, blood pressure, and waist circumference at 1 month, 3 months, and 6 months after the patient's initial visit. At the conclusion of the study, patients who were in the intervention group will be asked to take a final survey regarding the patient's use of the MyFitnessPal application.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMyFitnessPal userPatients will be counseled on how to use the MyFitnessPal application to help with the patient's weight loss goals. The physician will monitor the patient's weight, blood pressure, and waist circumference over up to a six month period with visits at 1, 3, and 6 months. Patients will be asked about the patient's use of the application at the end of the study.

Timeline

Start date
2022-05-09
Primary completion
2023-07-01
Completion
2023-08-01
First posted
2021-09-28
Last updated
2023-07-20

Source: ClinicalTrials.gov record NCT05059938. Inclusion in this directory is not an endorsement.